Zobrazeno 1 - 10
of 514
pro vyhledávání: '"Nicholas Carlson"'
Autor:
Pauline Knigge, Sørine Lundberg, Jarl E. Strange, Mariam E. Malik, Nina Nouhravesh, Andrea K. Wagner, Gunnar Gislason, Emil L. Fosbøl, Nicholas Carlson, Deewa Zahir, Charlotte Andersson, Jawad H. Butt, Pardeep Jhund, Mark C. Petrie, John J. V. McMurray, Lars Køber, Morten Schou
Publikováno v:
Journal of the American Heart Association: Cardiovascular and Cerebrovascular Disease, Vol 13, Iss 6 (2024)
Background The incidence and distribution of acute and chronic dialysis among patients with heart failure (HF), stratified by diabetes, remain uncertain. We hypothesized that with improved survival and rising comorbidities, the demand for dialysis wo
Externí odkaz:
https://doaj.org/article/b23f4c07f3714d46b62dc9fc1e7a620e
Autor:
Christian Torp-Pedersen, Rikke Borg, Ditte Hansen, Lars Køber, Morten Schou, Gunnar Gislason, Theis Lange, Jonas Bjerring Olesen, Jens Dam Jensen, Iain Bressendorff, Morten Lindhardt, Mads Hornum, Erik L Grove, Marianne Rix, Anne-Lise Kamper, Christian Daugaard Peters, Jan Dominik Kampmann, Dea Haagensen Kofod, Kristine Lindhard, Frank Holden Mose, Ellen Linnea Freese Ballegaard, Finn Thomsen Nielsen, Ida Nørager Tietze, Lene Boesby, Marianne Camilla Bertelsen, Julie Maria Bøggild Brøsen, Donata Cibulskyte-Ninkovic, Jesper Moesgaard Rantanen, Alice Skovhede Nielsen, Johanne Kodal Breinholt, Peter Vilhelm Clausen, Casper Niels Furbo Bang, Nicholas Carlson
Publikováno v:
BMJ Open, Vol 14, Iss 2 (2024)
Introduction Atrial fibrillation is highly prevalent in patients on chronic dialysis. It is unclear whether anticoagulant therapy for stroke prevention is beneficial in these patients. Vitamin K-antagonists (VKA) remain the predominant anticoagulant
Externí odkaz:
https://doaj.org/article/bab64788782d4769b515dc81aeed052a
Autor:
Dea Haagensen Kofod, Nicholas Carlson, Ellen Freese Ballegaard, Thomas Peter Almdal, Christian Torp-Pedersen, Gunnar Gislason, Jesper Hastrup Svendsen, Bo Feldt-Rasmussen, Mads Hornum
Publikováno v:
Cardiovascular Diabetology, Vol 22, Iss 1, Pp 1-11 (2023)
Abstract Background Cardiovascular mortality and the impact of cardiac risk factors in advanced chronic kidney disease (CKD) remain poorly investigated. We examined the risk of cardiovascular mortality in patients with advanced CKD with and without d
Externí odkaz:
https://doaj.org/article/4f57d81f7c3e4c76a1cc1a0ec3eda751
Autor:
Jeppe Kofoed Petersen, Lauge Østergaard, Nicholas Carlson, Lucas Grove Vejlstrup Bager, Jarl E. Strange, Morten Schou, Lars Køber, Emil Loldrup Fosbøl
Publikováno v:
Journal of the American Heart Association: Cardiovascular and Cerebrovascular Disease, Vol 13, Iss 1 (2024)
Background In patients undergoing transcatheter aortic valve replacement (TAVR), the impact of acute kidney injury (AKI) on the prognosis and especially on future kidney function has been sparsely examined, and data from large cohorts are warranted.
Externí odkaz:
https://doaj.org/article/fc40c124be114d9a8c2e0af441023b33
Publikováno v:
International Journal of Molecular Sciences, Vol 24, Iss 21, p 15953 (2023)
The current tools for validating dose delivery and optimizing new radiotherapy technologies in radiation therapy do not account for important dose modifying factors (DMFs), such as variations in cellular repair capability, tumor oxygenation, ultra-hi
Externí odkaz:
https://doaj.org/article/7b65d21b67644242b1541e8665392476
Autor:
Philip Andreas Schytz, Paul Blanche, Anders Bonde Nissen, Christian Torp-Pedersen, Gunnar H. Gislason, Karl Emil NELVEG-Kristensen, Kristine Hommel, Nicholas Carlson
Publikováno v:
Nefrología (English Edition), Vol 42, Iss 3, Pp 338-346 (2022)
Background: Acute kidney injury (AKI) has been associated with cardiovascular disease, but this is sparsely studied in non-selected populations and with little attention to the effect in age and renal function. Using nationwide administrative data, w
Externí odkaz:
https://doaj.org/article/e09760eaa06c42d68857198d1c53f450
Publikováno v:
International Journal of Nephrology, Vol 2023 (2023)
Chronic kidney disease (CKD) is becoming one of the world’s most prevalent noncommunicable chronic diseases. The World Health Organization projects CKD to become the 5th most common chronic disease in 2040. Causes of CKD are multifactorial and dive
Externí odkaz:
https://doaj.org/article/cb2009f475a74f10a9dfcd63353141c2
Autor:
Ida Maria Hjelm Sørensen, Sasha Asbøll Kepler Saurbrey, Henrik Øder Hjortkjær, Philip Brainin, Nicholas Carlson, Ellen Linnea Freese Ballegaard, Anne-Lise Kamper, Christina Christoffersen, Bo Feldt-Rasmussen, Klaus Fuglsang Kofoed, Susanne Bro
Publikováno v:
BMC Nephrology, Vol 21, Iss 1, Pp 1-11 (2020)
Abstract Background Patients with chronic kidney disease (CKD) and arterial calcification are considered at increased risk of adverse cardiovascular outcomes. However, the optimal site for measurement of arterial calcification has not been determined
Externí odkaz:
https://doaj.org/article/ee2d1f084ff3413b817b381c8fb21fa2
Autor:
Christina Boegh Jakobsen, Morten Lamberts, Nicholas Carlson, Morten Lock-Hansen, Christian Torp-Pedersen, Gunnar H. Gislason, Morten Schou
Publikováno v:
BMC Cancer, Vol 19, Iss 1, Pp 1-12 (2019)
Abstract Background The prevalence of both atrial fibrillation (AF) and malignancies are increasing in the elderly, but incidences of new onset AF in different cancer subtypes are not well described.The objectives of this study were therefore to dete
Externí odkaz:
https://doaj.org/article/c218c422716141999e3c017cd79feb14
Autor:
Emma Kirstine Laugesen, Laila Staerk, Nicholas Carlson, Anne-Lise Kamper, Jonas Bjerring Olesen, Christian Torp-Pedersen, Gunnar Gislason, Anders Nissen Bonde
Publikováno v:
Thrombosis Journal, Vol 17, Iss 1, Pp 1-8 (2019)
Abstract Background We aimed to compare effectiveness and safety of non-vitamin K antagonist oral anticoagulants (NOACs) versus vitamin-K antagonists (VKA) in atrial fibrillation (AF) patients with chronic kidney disease (CKD) not receiving dialysis.
Externí odkaz:
https://doaj.org/article/c0f216dd0ab9479e8586f4211f7358eb